Business Description
PAVmed Inc
NAICS : 334510
SIC : 3842
ISIN : US70387R4039
Description
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -0.16 | |||||
| Debt-to-Equity | -7.17 | |||||
| Debt-to-EBITDA | 2.96 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -11.83 | |||||
| Beneish M-Score | 5.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 2.6 | |||||
| 3-Year EPS without NRI Growth Rate | -3 | |||||
| 3-Year FCF Growth Rate | -1.3 | |||||
| 3-Year Book Growth Rate | -252.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 61.87 | |||||
| Future 3-5Y Total Revenue Growth Rate | 182.13 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 16.48 | |||||
| 12-1 Month Momentum % | -16.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 34.01 | |||||
| Days Sales Outstanding | 7.22 | |||||
| Days Payable | 81.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.3 | |||||
| Shareholder Yield % | -17.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -58.7 | |||||
| Operating Margin % | -1380.29 | |||||
| Net Margin % | 602.98 | |||||
| FCF Margin % | -1135.92 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 66.69 | |||||
| ROIC % | -97.97 | |||||
| ROC (Joel Greenblatt) % | 177.73 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 1.05 | |||||
| PS Ratio | 1.7 | |||||
| EV-to-EBIT | 4.02 | |||||
| EV-to-EBITDA | 3.39 | |||||
| EV-to-Forward-EBITDA | -1.1 | |||||
| EV-to-Revenue | 9.9 | |||||
| EV-to-Forward-Revenue | 5.2 | |||||
| EV-to-FCF | -0.87 | |||||
| Earnings Yield (Greenblatt) % | 24.88 | |||||
| FCF Yield % | -647 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PAVmed Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.697 | ||
| EPS (TTM) (€) | -4.208 | ||
| Beta | 0 | ||
| Volatility % | 37.57 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 2.63999 | ||
| 12-1 Month Momentum % | -16.54 | ||
| 52-Week Range (€) | 2.266404 - 5.852803 | ||
| Shares Outstanding (Mil) | 9.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PAVmed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PAVmed Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
PAVmed Inc Frequently Asked Questions
What is PAVmed Inc(FRA:1P50)'s stock price today?
The current price of FRA:1P50 is €2.64. The 52 week high of FRA:1P50 is €5.85 and 52 week low is €2.27.
When is next earnings date of PAVmed Inc(FRA:1P50)?
The next earnings date of PAVmed Inc(FRA:1P50) is 2025-03-27 Est..
Does PAVmed Inc(FRA:1P50) pay dividends? If so, how much?
PAVmed Inc(FRA:1P50) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers